135 results on '"Esophageal cancer -- Patient outcomes"'
Search Results
2. Data from Biomedical Center Update Knowledge in Gastric Cancer (Survival improvements in esophageal and gastric cancers in the Nordic countries favor younger patients)
3. Researchers at Harbin Institute of Technology Release New Study Findings on Esophageal Cancer [Neoadjuvant immunochemotherapy improves clinical outcomes of patients with esophageal cancer by mediating anti-tumor immunity of CD8+ T (Tc1) and ...]
4. Would you know the symptoms of some of Wales' deadliest cancers? Oesophageal and stomach cancer have some of the worst survival rates in Wales; Oesophageal and stomach cancer have some of the worst survival rates in Wales
5. Findings from Sichuan University Provide New Insights into Esophageal Cancer (Substitute or coexistence? mediastinoscopy-assisted versus thoracoscope-assisted esophagectomy in esophageal cancer - a meta-analysis of perioperative outcomes and ...)
6. Study Results from University of Florida in the Area of Esophageal Cancer Reported (Association of Medical Appointment Cancellation Rates On Survival After Esophagectomy for Esophageal Cancer)
7. Study Data from University of Electronic Science and Technology of China Update Knowledge of Squamous Cell Carcinoma (Impact of Metastatic Lymph Nodes On Survival of Patients With Pn1-category Esophageal Squamous Cell Carcinoma: a Long-term ...)
8. Identification of plasma proteins associated with oesophageal cancer chemotherapeutic treatment outcomes using SWATH-MS
9. University Medical Center Hamburg-Eppendorf Researchers Have Provided New Data on Esophageal Cancer (High Serum Levels of Wnt Signaling Antagonist Dickkopf-Related Protein 1 Are Associated with Impaired Overall Survival and Recurrence in ...)
10. New Esophageal Cancer Study Findings Recently Were Reported by BinBin Li and Co-Researchers (Impact of Minimally Invasive Esophagectomy in Post-Operative Atrial Fibrillation and Long-Term Mortality in Patients Among Esophageal Cancer)
11. Investigators at Cancer Institute Hospital of Japanese Foundation for Cancer Research Zero in on Esophageal Cancer (Influence of Preoperative Oropharyngeal Microflora on the Occurrence of Postoperative Pneumonia and Survival in Patients ...)
12. Study Findings on Esophageal Cancer Are Outlined in Reports from Ohio State University (The Academic Facility Is Associated With Higher Utilization of Esophagectomy and Improved Overall Survival for Esophageal Carcinoma)
13. Reports Outline Esophageal Cancer Study Results from University Medical Center Utrecht (Patient-reported outcomes after external beam radiotherapy versus brachytherapy for palliation of dysphagia in esophageal cancer: a matched comparison of ...)
14. Researchers' Work from Guangdong Esophageal Cancer Institute Focuses on Squamous Cell Carcinoma (Lymphopenia During Definitive Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Association with Dosimetric Parameters and Patient Outcomes)
15. Researchers at Karolinska University Hospital Discuss Findings in Esophageal Cancer (Surgical Morbidity and Mortality From the Multicenter Randomized Controlled NeoRes II Trial: Standard Versus Prolonged Time to Surgery After Neoadjuvant ...)
16. Investigators at Liaocheng People's Hospital Report New Data on Squamous Cell Carcinoma (Low Lymphocyte Count Is Associated With Radiotherapy Parameters and Affects the Outcomes of Esophageal Squamous Cell Carcinoma Patients)
17. New Esophageal Cancer Study Findings Recently Were Reported by Researchers at Karolinska Institute (Patient Age and Survival After Surgery for Esophageal Cancer)
18. Data on Squamous Cell Carcinoma Described by Researchers at National Cancer Center Hospital (Long-term outcomes of patients with recurrent squamous cell carcinoma of the esophagus undergoing salvage endoscopic resection after definitive ...)
19. New Phase III data show Novartis tislelizumab significantly extended median overall survival by more than 6 months in first-line advanced esophageal cancer in combination with chemotherapy
20. Data on Esophageal Cancer Detailed by a Researcher at Zanjan University of Medical Sciences (The Comparative Effect of Definitive Chemoradiotherapy and Neoadjuvant Chemoradiotherapy Plus Surgery on One-Year Survival Rate of Esophageal Cancer ...)
21. Reports from Hebei Medical University Highlight Recent Findings in Squamous Cell Carcinoma (Novel Nomograms Predicting the Survival of Patients With Nonsurgical Thoracic Esophageal Squamous Cell Carcinoma Treated With Imrt: a Retrospective ...)
22. UT Health San Antonio thoracic surgery team achieves highly coveted ranking for lung, esophageal cancer outcomes
23. UT Health San Antonio thoracic surgery team achieves highly coveted ranking for lung, esophageal cancer outcomes
24. Exercise Might Boost Outcomes for People Battling Esophageal Cancer
25. Exercise Might Boost Outcomes for People Battling Esophageal Cancer
26. New Esophageal Cancer Data Have Been Reported by Researchers at Tohoku University Graduate School of Medicine (FDG-PET might not contribute to improving survival in patients with locally advanced inoperable esophageal cancer)
27. Data from Kaohsiung Chang Gung Memorial Hospital Advance Knowledge in Squamous Cell Carcinoma (The Clinical Outcomes of Locally Advanced Cervical Esophageal Squamous Cell Carcinoma Patients Receiving Curative Concurrent Chemoradiotherapy: a ...)
28. Findings from Wuhan University Update Understanding of Squamous Cell Carcinoma (Outcomes of Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Esophageal Squamous Cell Cancer Patients Presenting With Oligometastases)
29. Findings from University Medical Center in Esophageal Cancer Reported [Detection of Distant Interval Metastases After Neoadjuvant Therapy for Esophageal Cancer With F-18-fdg Pet(/ct): a Systematic Review and Meta-analysis]
30. Investigators from Ohio State University Target Esophageal Cancer (The Academic Facility Is Associated With Higher Utilization of Esophagectomy and Improved Overall Survival for Esophageal Carcinoma)
31. Sun Yat-sen University Cancer Center Researchers Update Current Study Findings on Squamous Cell Carcinoma (A Nomogram Model to Predict Post-Progression Survival in Esophageal Squamous Cell Carcinoma Patients With Recurrence After Radical ...)
32. Coherus and Junshi Biosciences to Present Positive Progression Free Survival and Overall Survival Results from JUPITER-06, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma
33. Junshi Biosciences and Coherus to Present Positive Progression Free Survival and Overall Survival Results from JUPITER-06, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma
34. Junshi Biosciences and Coherus to Present Positive Progression Free Survival and Overall Survival Results from JUPITER-06, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma
35. Clinical utility of postchemoradiation endoscopic brush cytology and biopsy in predicting residual esophageal adenocarcinoma
36. Biomarkers of response to therapy in oesophago-gastric cancer
37. Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study
38. Abnormalities of chromosome 17 in oesophageal cancer
39. Increased E2F-1 expression via tumour cell proliferation and decreased apoptosis are correlated with adverse prognosis in patients with squamous cell carcinoma of the oesophagus
40. Switzerland : Novartis investigational checkpoint inhibitor tislelizumab met primary endpoint of overall survival in pivotal Phase III trial of esophageal cancer after systemic therapy
41. Novartis investigational checkpoint inhibitor tislelizumab met primary endpoint of overall survival in pivotal Phase III trial of esophageal cancer after systemic therapy
42. Novartis investigational checkpoint inhibitor tislelizumab met primary endpoint of overall survival in pivotal Phase III trial of esophageal cancer after systemic therapy
43. Bristol Myers Squibb Presents Data from CheckMate -648 Showing Opdivo plus Chemotherapy and Opdivo plus Yervoy Significantly Improved Overall Survival Compared to Chemotherapy in Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma
44. Novartis investigational checkpoint inhibitor tislelizumab met primary endpoint of overall survival in pivotal Phase III trial of esophageal cancer after systemic therapy
45. Bristol Myers Squibb Presents Data from CheckMate -648 Showing Opdivo plus Chemotherapy and Opdivo plus Yervoy Significantly Improved Overall Survival Compared to Chemotherapy in Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma
46. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial
47. Coherus Announces Toripalimab Achieved Primary Endpoints of Progression Free Survival and Overall Survival in Interim Analysis of Phase 3 Clinical Trial in First-Line Esophageal Squamous Cell Carcinoma
48. Coherus Announces Toripalimab Achieved Primary Endpoints of Progression Free Survival and Overall Survival in Interim Analysis of Phase 3 Clinical Trial in First-Line Esophageal Squamous Cell Carcinoma
49. Impact of chemotherapy on quality of life in patients with metastatic esophagogastric cancer
50. Weekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.